|RCUS||ARCUS BIOSCIENCES INC||2.19%|
|ALNY||ALNYLAM PHARMACEUTICALS INC.||1.91%|
|SYNH||SYNEOS HEALTH INC||1.88%|
|TMO||THERMO FISHER SCIENTIFIC INC||1.86%|
|UNH||UNITEDHEALTH GROUP INC||1.86%|
|LLY||ELI LILLY CORP||1.77%|
|BMY||BRISTOL MYERS SQUIBB CO||1.77%|
|BDX||BECTON DICKINSON & CO||1.76%|
|RARE||ULTRAGENYX PHARMACEUTICAL INC||1.75%|
|XRAY||DENTSPLY SIRONA INC||1.75%|
|ARWR||ARROWHEAD PHARMACEUTICALS INC||1.74%|
|EW||EDWARDS LIFESCIENCES CORP||1.74%|
|SRPT||SAREPTA THERAPEUTICS INC||1.71%|
|UTHR||UNITED THERAPEUTICS CORPS||1.70%|
|HZNP||HORIZON THERAPEUTICS PLC||1.68%|
|ARVN||ARVINAS INC USD||1.67%|
|ITCI||INTRA-CELLULAR THERAPIES USD||1.66%|
|HCA||HCA HOLDINGS INC||1.66%|
|IMAB||I-MAB CNY 0.0001 ADR||1.66%|
|MTD||METTLER-TOLEDO INTERNATIONAL INC||1.64%|
|GH||GUARDANT HEALTH INC||1.63%|
|KRTX||KARUNA THERAPEUTICS, INC.||1.60%|
|ASND||ASCENDIS PHARMA A/S DKK 1.0 ADR||1.60%|
|BHVN||BIOHAVEN PHARMACEUTICAL HOLDING NPV||1.60%|
|KYMR||KYMERA THERAPEUTICS INC||1.59%|
|ARNA||ARENA PHARMACEUTICALS INC||1.55%|
|ADUS||ADDUS HOMECARE CORPORATION||1.52%|
|BPMC||BLUEPRINT MEDICINES CORPORATION||1.51%|
|CRSP||CRISPR THERAPEUTICS AG||1.48%|
|CRBU||CARIBOU BIOSCIENCES INC||1.48%|
|NTLA||INTELLIA THERAPEUTICS INC||1.44%|
|PACB||PACIFIC BIOSCIENCES OF CALIF||1.42%|
|BEAM||BEAM THERAPEUTICS INC||1.40%|
|ALGN||ALIGN TECHNOLOGY INC||1.33%|
|MORF||MORPHIC HLDG INC||1.32%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2021 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.